• RAVI SHANKAR Department of Biochemistry, Pacific Institute of Medical Sciences, Udaipur, Rajasthan, India
  • AJAY KUMAR Department of Biochemistry, Pacific Institute of Medical Sciences, Udaipur, Rajasthan, India.
  • NEHA SHARMA Department of Biochemistry, Shri Atal Bihari Vajpayee Government Medical College, Faridabad, Haryana, India
  • RAJU RAM Department of Biochemistry, M. K. Shah Medical College and Research Centre, Ahmadabad, Gujarat, India.
  • APARAJITA KUSHWAHA Department of Biochemistry, Pacific Medical College and Hospital, Udaipur, Rajasthan, India.



Malondialdehyde, Vitamin C,, Thyroid,, Metabolic syndrome, Inflammation


Objectives: Metabolic syndrome is the most widely used term for the aggregation of metabolic abnormalities, which leads to an increase in the risk of developing cardiovascular pathology. Protective nutritional antioxidants may benefit defensive antioxidative systems in resolving pro-oxidative dominance and redox imbalance, preventing, or delaying chronic thyroid diseases.

Methods: This cross-sectional, observational study was conducted among metabolic syndrome patients in the general population and near and dear patients (350) at the Pacific Institute of Medical Sciences, Udaipur. For the determination of interleukin-6 (IL-6) was done by enzyme-linked immunosorbent assay. Thyroid hormones are determined by chemiluminescence and antioxidant Vitamin C and malondialdehyde (MDA) chromatography and high-performance liquid chromatography, respectively.

Results: This study shows a low level of antioxidant Vitamin C and MDA and a high level of inflammatory marker IL-6 in these patients. In this study, the age distribution of patients showed that males in the 35–51 years of age group were most affected, whereas females in the 18–34 years of age group were more prevalent.

Conclusion: The present study leads to awareness of antioxidant levels and inflammation in thyroid patients along with other biochemical parameters involved in the development of metabolic syndrome in the Indian population.


Download data is not yet available.


Rochlani Y, Pothineni NV, Kovelamudi S, Mehta JL. Metabolic syndrome: Pathophysiology, management, and modulation by natural compounds. Ther Adv Cardiovasc Dis. 2017;11(8):215-25. doi: 10.1177/1753944717711379, PMID: 28639538

Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414(6865):782-7. doi: 10.1038/414782a, PMID: 11742409

Mohan V, Deepa M, Deepa R, et al. The burden and determinants of undiagnosed diabetes in India: The cross-sectional, population-based, Indian Council of Medical Research-India Diabetes (ICMR-INDIAB) study. Lancet Diabetes Endocrinol. 2019;7:123-32.

Kochman J, Jakubczyk K, Bargiel P, Janda-Milczarek K. The influence of oxidative stress on thyroid diseases. Antioxidants (Basel). 2021 Sep 10;10(9):1442. doi: 10.3390/antiox10091442, PMID: 34573074, PMCID: PMC8465820

Moore JX, Chaudhary N, Akinyemiju T. Metabolic syndrome prevalence by race/ethnicity and sex in the United States, national health and nutrition examination survey, 1988-2012. Prev Chronic Dis. 2017;14:E24. doi: 10.5888/pcd14.160287, PMID: 28301314

Shantha GP, Kumar AA, Jeyachandran V, Rajamanickam D, Rajkumar K, Salim S, et al. Association between primary hypothyroidism and metabolic syndrome and the role of C reactive protein: A cross-sectional study from South India. Thyroid Res. 2009;2(1):2. doi: 10.1186/1756-6614-2-2, PMID: 19272156

Udenze I, Nnaji I, Oshodi T. Thyroid function in adult Nigerians with metabolic syndrome. Pan Afr Med J. 2014;18:352. doi: 10.11604/ pamj.2014.18.352.4551. PMID: 25574328

Gyawali P, Takanche JS, Shrestha RK, Bhattarai P, Khanal K, Risal P, et al. Pattern of thyroid dysfunction in patients with metabolic syndrome and its relationship with components of metabolic syndrome. Diabetes Metab J. 2015;39(1):66-73. doi: 10.4093/dmj.2015.39.1.66, PMID: 25729715

Kota SK, Meher LK, Krishna S, Modi K. Hypothyroidism in metabolic syndrome. Indian J Endocrinol Metab. 2012;16;Suppl 2:S332-3. doi: 10.4103/2230-8210.104079, PMID: 23565417

Cell Bio Labs, Inc. Human Apo(a) ELISA Kit Catalog Number STA- 359. San Diego: Cell Biolabs; 2012-2015.

Eagle Bioscience, Inc. Human Apo(B) ELISA Kit Catalog Number ARG81098. Nashua, NH: Arigo Biolaboratories;2016..

Srikanthan K, Feyh A, Visweshwar H, Shapiro JI, Sodhi K. Systematic review of metabolic syndrome biomarkers: A panel for early detection, management, and risk stratification in the West Virginian population. Int J Med Sci. 2016;13(1):25-38. doi: 10.7150/ijms.13800. PMID: 26816492

Limberg JK, Harrell JW, Johansson RE, Eldridge MW, Proctor LT, Sebranek JJ, et al. Microvascular function in younger adults with obesity and metabolic syndrome: Role of oxidative stress. Am J Physiol Heart Circ Physiol. 2013;305(8):H1230-7. doi: 10.1152/ajpheart.00291.2013, PMID: 23934859

Perticone F, Ceravolo R, Candigliota M, Ventura G, Iacopino S, Sinopoli F, et al. Obesity and body fat distribution induce endothelial dysfunction by oxidative stress: Protective effect of vitamin C. Diabetes. 2001;50(1):159-65. doi: 10.2337/diabetes.50.1.159, PMID: 11147782

Ter Horst R, Van den Munckhof IC, Schraa K, Aguirre-Gamboa R, Jaeger M, Smeekens SP, et al. Sex-specific regulation of inflammation and metabolic syndrome in obesity. Arterioscler Thromb Vasc Biol. 2020;40(7):1787-800. doi: 10.1161/ATVBAHA.120.314508, PMID: 32460579

Brenta G, Pisarikova M, Elbert N. Inflammatory markers in thyroid dysfunction and metabolic syndrome. Endocr Rev. 2020;41(2):45-63. doi: 10.1210/endrev/bnz012

Wróblewski M, Wróblewska J, Nuszkiewicz J, Pawłowska M, Wesołowski R, Woźniak A. The role of selected trace elements in oxidoreductive homeostasis in patients with thyroid diseases. Int J Mol Sci. 2023;24(5):4840. doi: 10.3390/ijms24054840, PMID: 36902266

Morelli MB, Gambardella J, Castellanos V, Trimarco V, Santulli G. Vitamin C and cardiovascular disease: An update. Antioxidants (Basel). 2020;9(12):1227. doi: 10.3390/antiox9121227, PMID: 33287462



How to Cite

RAVI SHANKAR, AJAY KUMAR, NEHA SHARMA, RAJU RAM, and APARAJITA KUSHWAHA. “ROLE OF ANTIOXIDANT AND INFLAMMATORY MARKERS WITH METABOLIC SYNDROME AND RISK OF CVD IN THYROID PATIENTS”. Asian Journal of Pharmaceutical and Clinical Research, vol. 17, no. 7, July 2024, pp. 153-8, doi:10.22159/ajpcr.2024v17i7.51845.



Original Article(s)